Trial intelligence / Profile preview

Hyperbaric Oxygen Therapy for Osteoradionecrosis of the Jaw

NCT00989820Phase 3Terminated

Sponsor
Radboud University Medical Center
Start
Oct 2009
Primary completion
May 2017
Modality
NPI (Non-Pharmacological Intervention)
Countries
1
01

Overview

A Phase 3 trial of hyperbaric oxygen therapy in osteoradionecrosis (ORN), sponsored by Radboud University Medical Center. Started Oct 2009; status: terminated.

02

Drugs

hyperbaric oxygen therapy
03

Conditions

osteoradionecrosis (ORN)

Beyond the preview

Go deeper on NCT00989820.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00989820.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call